Durable Response to Immune Checkpoint Blockade Plus Albumin-Bound Paclitaxel in Two Osimertinib-Refractory Patients with EGFR-mutated Lung Adenocarcinoma
Osimertinib (AZD9291, Tagrisso) is an irreversible third-generation epidermal growth factor receptor

